indomethacin has been researched along with Acquired Nephrogenic Diabetes Insipidus in 10 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We report a case of congenital nephrogenic diabetes insipidus that was complicated by paradoxical water intoxication secondary to liberal water intake and the initiation of hydrochlorothiazide and indomethacin combination therapy." | 3.75 | Nephrogenic diabetes insipidus: treat with caution. ( Boussemart, T; Champion, G; Martin-Coignard, D; Nsota, J, 2009) |
| "Indomethacin 150 mg was started and urine volume immediately fell to one-half." | 2.40 | Emergency treatment of lithium-induced diabetes insipidus with nonsteroidal anti-inflammatory drugs. ( Kjellstrand, C; Lam, SS, 1997) |
| "Two children with nephrogenic diabetes insipidus (NDI) were treated with oral indomethacin (0." | 1.42 | Response to low dose indomethacin in two children with nephrogenic diabetes insipidus. ( Dayal, D; Kumar Bhalla, A; Kumar, R; Verma Attri, S, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peng, D | 1 |
| Dai, Y | 1 |
| Xu, X | 1 |
| Caletti, MG | 1 |
| Balestracci, A | 1 |
| Di Pinto, D | 1 |
| Schreuder, MF | 1 |
| Koster-Kamphuis, L | 1 |
| Dayal, D | 1 |
| Verma Attri, S | 1 |
| Kumar Bhalla, A | 1 |
| Kumar, R | 1 |
| Bockenhauer, D | 1 |
| Cruwys, M | 1 |
| Kleta, R | 1 |
| Halperin, LF | 1 |
| Wildgoose, P | 1 |
| Souma, T | 1 |
| Nukiwa, N | 1 |
| Cheema-Dhadli, S | 1 |
| Chong, CK | 1 |
| Kamel, KS | 1 |
| Davids, MR | 1 |
| Halperin, ML | 1 |
| Boussemart, T | 1 |
| Nsota, J | 1 |
| Martin-Coignard, D | 1 |
| Champion, G | 1 |
| Le Roy, V | 1 |
| Delmas, Y | 1 |
| Verdoux, H | 1 |
| Zaki, M | 1 |
| Schöneberg, T | 1 |
| Al Ajrawi, T | 1 |
| Al Said, AN | 1 |
| Sangkuhl, K | 1 |
| Römpler, H | 1 |
| Höhler, T | 1 |
| Teuber, G | 1 |
| Wanitschke, R | 1 |
| Meyer zum Büschenfeld, KH | 1 |
| Lam, SS | 1 |
| Kjellstrand, C | 1 |
2 reviews available for indomethacin and Acquired Nephrogenic Diabetes Insipidus
| Article | Year |
|---|---|
[Chronic renal complications induced by lithium].
Topics: Amiloride; Anti-Inflammatory Agents, Non-Steroidal; Antimanic Agents; Bipolar Disorder; Diabetes Ins | 2009 |
Emergency treatment of lithium-induced diabetes insipidus with nonsteroidal anti-inflammatory drugs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Creatinine; Diabetes Insipidus, Nephrogenic; Female; Humans | 1997 |
8 other studies available for indomethacin and Acquired Nephrogenic Diabetes Insipidus
| Article | Year |
|---|---|
Identification of a novel X-linked arginine-vasopressin receptor 2 mutation in nephrogenic diabetes insipidus: Case report and pedigree analysis.
Topics: Asian People; Diabetes Insipidus, Nephrogenic; Humans; Hydrochlorothiazide; Indomethacin; Receptors, | 2019 |
Pre- and post-treatment urinary tract findings in children with nephrogenic diabetes insipidus.
Topics: Amiloride; Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; Combined Modality Thera | 2014 |
Poiseuille's law in polyuria.
Topics: Amiloride; Anti-Inflammatory Agents, Non-Steroidal; Diabetes Insipidus, Nephrogenic; Diuretics; Huma | 2014 |
Response to low dose indomethacin in two children with nephrogenic diabetes insipidus.
Topics: Child; Child, Preschool; Diabetes Insipidus, Nephrogenic; Dose-Response Relationship, Drug; Humans; | 2015 |
Antenatal Bartter's syndrome: why is this not a lethal condition?
Topics: Animals; Aquaporin 1; Bartter Syndrome; Chlorides; Diabetes Insipidus, Nephrogenic; Humans; Hyperald | 2008 |
Nephrogenic diabetes insipidus: treat with caution.
Topics: Amiloride; Combined Modality Therapy; Cyclooxygenase Inhibitors; Diabetes Insipidus, Nephrogenic; Di | 2009 |
Nephrogenic diabetes insipidus, thiazide treatment and renal cell carcinoma.
Topics: Amino Acid Sequence; Aquaporin 2; Carcinoma, Renal Cell; Cardiovascular Agents; Diabetes Insipidus, | 2006 |
Indomethacin treatment in amphotericin B induced nephrogenic diabetes insipidus.
Topics: Amphotericin B; Diabetes Insipidus, Nephrogenic; Diuresis; Female; Humans; Indomethacin; Kidney; Leu | 1994 |